欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0912/001
药品名称Micafungin Teva 50 mg Powder for Concentrate for Solution for Infusion
活性成分
    • micafungin sodium salt 50.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Teva B.V. Swensweg 5 2031 GA Haarlem, The Netherlands
参考成员国 - 产品名称Austria (AT)
Micafungin ratiopharm 50 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
      Micafungin Teva
    • Hungary (HU)
      MICAFUNGIN-TEVA 50 mg por oldatos infúzióhoz való koncentrátumhoz
    • Slovenia (SI)
    • Croatia (HR)
      Mikafungin Teva 50 mg prašak za otopinu za infuziju
许可日期2019/09/23
最近更新日期2024/08/20
药物ATC编码
    • J02AX05 micafungin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase